Found: 20
Select item for more details and to access through your institution.
Clinical impact of postprogression survival for overall survival in elderly patients (aged 75 years or older) with advanced nonsmall cell lung cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Papillary adenocarcinoma of the lung is a more advanced adenocarcinoma than bronchioloalveolar carcinoma that is composed of two distinct histological subtypes.
- Published in:
- Pathology International, 2005, v. 55, n. 10, p. 619, doi. 10.1111/j.1440-1827.2005.01879.x
- By:
- Publication type:
- Article
Epigenetic Inactivation of the Thyroid Hormone Receptor β1 Gene at 3p24.2 in Lung Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2010, v. 17, n. 8, p. 2222, doi. 10.1245/s10434-010-0956-9
- By:
- Publication type:
- Article
High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinoma.
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 5, p. 872, doi. 10.1007/s10147-017-1142-x
- By:
- Publication type:
- Article
Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors.
- Published in:
- Oncogene, 2003, v. 22, n. 49, p. 7862, doi. 10.1038/sj.onc.1207082
- By:
- Publication type:
- Article
Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells.
- Published in:
- Oncogene, 2001, v. 20, n. 43, p. 6258, doi. 10.1038/sj.onc.1204832
- By:
- Publication type:
- Article
Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma.
- Published in:
- Oncogene, 1999, v. 18, n. 4, p. 1007, doi. 10.1038/sj.onc.1202384
- By:
- Publication type:
- Article
Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel as Second- or Third-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer.
- Published in:
- Chemotherapy (0009-3157), 2020, v. 65, n. 1-2, p. 21, doi. 10.1159/000508715
- By:
- Publication type:
- Article
Post-Progression Survival Associated with Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Docetaxel Monotherapy as Second-Line Chemotherapy.
- Published in:
- Chemotherapy (0009-3157), 2017, v. 62, n. 4, p. 205, doi. 10.1159/000456534
- By:
- Publication type:
- Article
Efficacy and Safety of Platinum Combination Chemotherapy Re-Challenge for Relapsed Patients with Non-Small-Cell Lung Cancer after Postoperative Adjuvant Chemotherapy of Cisplatin plus Vinorelbine.
- Published in:
- Chemotherapy (0009-3157), 2014, v. 59, n. 4, p. 307, doi. 10.1159/000356155
- By:
- Publication type:
- Article
Single-nucleotide polymorphism (c.309T>G) in the MDM2 gene and lung cancer risk.
- Published in:
- Biomedical Reports, 2014, v. 2, n. 5, p. 719, doi. 10.3892/br.2014.305
- By:
- Publication type:
- Article
Genetic and epigenetic inactivation of LTF gene at 3p21.3 in lung cancers.
- Published in:
- International Journal of Cancer, 2006, v. 118, n. 4, p. 797, doi. 10.1002/ijc.21462
- By:
- Publication type:
- Article
Identification and Characterization of Families with Aggregation of Lung Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 1998, v. 28, n. 3, p. 192, doi. 10.1093/jjco/28.3.192
- By:
- Publication type:
- Article
A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase I study of nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
First-line gefitinib treatment in elderly patients (aged ≥75 years) with non-small cell lung cancer harboring EGFR mutations.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Phenotypic alterations of small cell lung carcinoma induced by different levels of wild-type p53 expression.
- Published in:
- Cell Death & Differentiation, 1998, v. 5, n. 2, p. 148, doi. 10.1038/sj.cdd.4400325
- By:
- Publication type:
- Article
Primary Sjogren's syndrome complicated by bilateral pleural effusion.
- Published in:
- Respirology, 2008, v. 13, n. 1, p. 155, doi. 10.1111/j.1440-1843.2007.01149.x
- By:
- Publication type:
- Article
Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors.
- Published in:
- Oncology Letters, 2017, v. 14, n. 2, p. 2369, doi. 10.3892/ol.2017.6419
- By:
- Publication type:
- Article